Docosahexaenoic and eicosapentaenoic fatty acids differentially regulate glucose and fatty acid metabolism in L6 rat skeletal muscle cells.
Level 5 - mechanism / opinion, no new human data
In vitro mechanistic laboratory study using a rat cell line without human data.
PubMed 32966124 · doi:10.1152/ajpcell.00304.2020
What was done
L6 rat skeletal muscle cells were incubated with 50 µM of either docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) for 1, 3, and 5 days. Investigators measured basal and insulin-stimulated glucose uptake, glycogen synthesis, signaling phosphorylation (AKT, GSK3, AMPK), protein expression of CPT1b and PGC-1α, glucose and palmitate oxidation rates, and anti-inflammatory markers.
What was found
Neither DHA nor EPA altered basal or insulin-stimulated glucose uptake, glycogen synthesis, AKT phosphorylation, or GSK3 phosphorylation. DHA treatment consistently elevated glucose and palmitate oxidation, whereas EPA increased oxidation only transiently. DHA alone caused sustained increases in AMPK phosphorylation and protein expression of CPT1b and PGC-1α. DHA also demonstrated a greater anti-inflammatory effect than EPA. The abstract reports no numerical values, effect sizes, or confidence intervals.
Why it matters
These findings suggest that DHA and EPA exert distinct direct metabolic effects in skeletal muscle, with DHA demonstrating superior potential to promote fatty acid and glucose oxidation pathways.
Limits
The study was conducted strictly in vitro using a rat skeletal muscle cell line (L6), which cannot replicate complex human systemic metabolism or physiological bioavailability. The abstract does not disclose replicate counts, statistical margins, or exact numerical values.
Cited by
- supports Certain omega-3 fatty acids increase carnitine palmitoyltransferase activity and augment fat oxidation.